Brief Reports
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 28, 2005; 11(40): 6385-6388
Published online Oct 28, 2005. doi: 10.3748/wjg.v11.i40.6385
Figure 1
Figure 1 SL-174T treated with different concentrations of L-NAME. A: Control; B: 0.2 mmol/L; C: 0.4 mmol/L; D: 0.8 mmol/L; E: 1.0 mmol/L. Data are represented as mean±SD of triplicate determinations.
Figure 2
Figure 2 Invasion and migration of different groups of SL-174T cells (×200). A: Invasion of control group cells; B: 0.8 mmol/L L-NAME invasion group; C: migration of control group; D: 0.8 mmol/L L-NAME migration group.
Figure 3
Figure 3 A: Expression of MMP-2 mRNA in SL-174T cells treated with different concentrations of L-NAME. M: Marker; lane 1: control; lanes 2-5: SL-174T cells treated with 0.2, 0.4, 0.8, and 1.0 mmol/L of L-NAME, respectively. The experiments were carried out in triplicate. Data are expressed as mean±SD; B: Expression of TIMP-2 mRNA in SL-174T cells treated with different concentrations of L-NAME. M: Marker; lane 1: control; lanes 2-5: SL-174T cells treated with 0.2, 0.4, 0.8, and 1.0 mmol/L of L-NAME, respectively. The experiments were carried out in triplicate. Data are expressed as mean±SD.